Lodoco (colchicine 0.5 mg tablets) — Medica

Atherosclerotic disease

Initial criteria

Patient is age ≥ 18 years
Patient has had one of the following conditions or diagnoses (i, ii, iii, iv, v, or vi): i. A previous myocardial infarction or a history of an acute coronary syndrome; OR ii. Angina (stable or unstable); OR iii. A past history of stroke or transient ischemic attack; OR iv. Coronary artery disease; OR v. Peripheral arterial disease; OR vi. Patient has undergone a coronary or other arterial revascularization procedure in the past (e.g., coronary artery bypass graft surgery, percutaneous coronary intervention, angioplasty, and coronary stent procedures)
According to the prescriber, Lodoco is being added onto background regimens of other atherosclerotic disease medications (e.g., aspirin, antiplatelet agents such as clopidogrel or ticagrelor, anticoagulants, lipid-lowering agents such as statins, beta blockers, angiotensin-converting enzyme inhibitors, or angiotensin receptor blockers)
According to the prescriber, the patient does not have severe hepatic impairment

1 year